Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T06:56:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:35:13.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:42:01.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:59:02.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has added a facility name and location related to Hemic and Lymphatic Diseases, specifically mentioning Lymphoma, Follicular, and pembrolizumab, while removing various related terms and resources.
    Difference
    4%
    Check dated 2025-08-31T12:19:08.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-24T08:13:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.